PODD: Insulet Corporation Stock

by  •  • Comments Off on PODD: Insulet Corporation Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 12,093.58
Enterprise Value ($M) 12,805.18
Book Value ($M) 732.70
Book Value / Share 10.46
Price / Book 16.51
NCAV ($M) -272.60
NCAV / Share -3.89
Price / NCAV -44.36

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.09
Return on Equity (ROE) 0.41

Liquidity (mrq)
Quick Ratio 2.62
Current Ratio 3.51

Balance Sheet (mrq) ($M)
Current Assets 1,582.90
Assets 2,588.20
Liabilities 1,855.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,697.10
Operating Income 208.50
Net Income 206.30
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 145.70
Cash from Investing -119.40
Cash from Financing -13.60

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 11.50 1.60
02-09 13G/A Capital Research Global Investors 13.60 54.06
02-09 13G/A Capital World Investors 3.30 -43.57
02-09 13G/A Fmr Llc 8.45 -10.95
02-08 13G/A Wellington Management Group Llp 4.87 -40.34
01-25 13G/A BlackRock Inc. 8.70 16.36
10-10 13G/A FIL Ltd 9.49

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-17 111,127 579,467 19.18
2024-04-16 104,398 235,113 44.40
2024-04-15 189,409 301,910 62.74
2024-04-12 138,281 279,173 49.53

(click for more detail)

Similar Companies
OFIX – Orthofix Medical Inc. OM – Outset Medical, Inc.
OSUR – OraSure Technologies, Inc. PSTX – Poseida Therapeutics, Inc.
SGHT – Sight Sciences, Inc.


Financial data and stock pages provided by
Fintel.io